Joseph Aragon, MD

New Heparin Dosing Regimen for Diabetics Undergoing Percutaneous Coronary Intervention

08/01/2008

Gregory Valania , MD;

James R. Wilentz , MD;

Joseph Aragon , MD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Aslam Khan , MD;

Raj R. Makkar , MD;

Howard Levitt , MD;

Varinder Singh , MD;

Amit Kamra , MD;

Salvatore Rametta , MD;

Unfractionated heparin is the primary anticoagulant administered prior to percutaneous coronary intervention (PCI) to prevent the generation of thrombin at the site of balloon-induced arterial injury and to reduce the thrombogenicity of the...

Unfractionated heparin is the...

08/01/2008

Journal of Invasive Cardiology

Case Report

Intracoronary Brachytherapy for In-Stent Restenosis of the Left Anterior Descending Artery Via the Left Internal Mammary Artery

08/01/2008

Joseph Aragon , MD;

Frank Litvak , MD;

Intravascular radiation is currently the only Food and Drug Administration-approved modality to treat in-stent restenosis (ISR).1,2 Multiple clinical trials have shown efficacy of beta-radiation in reducing intimal growth associated with...

Intravascular radiation is...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Multicenter International Registry of Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention with Everolimus-Eluting Stents

06/29/2012

Imad Sheiban , MD;

Si-Hyuck Kang , MD;

Ehtisham Mahmud , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Khalid Bin Thani , MD;

Hyo-Soo Kim , MD, PhD;

Michael S. Lee , MD, DPM, FACFAS, FACC, FSCAI;

Jang-Hyun Cho , MD;

Dong-Kyu Jin , MD;

Kyle Gillis , BS ;

Hyeon-Cheol Gwon , MD;

In-Ho Chae , MD;

Richard K. Cheng , MD, MS;

Joseph Aragon , MD;

Abstract: Objective. The aim of this study was to assess the clinical outcomes of percutaneous coronary intervention (PCI) with everolimus-eluting stents (EES) for the treatment of unprotected left main coronary artery (ULMCA) disease....

Abstract: Objective. The aim of...

06/29/2012

Journal of Invasive Cardiology